Is Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta-analysis.

BioMed Research International
Ziqin CaoRen Wu

Abstract

Most guidelines recommend the use of nonsteroidal anti-inflammatory drugs (NSAIDs), duloxetine, and tramadol for the nonoperative treatment of osteoarthritis (OA), but the use of them is limited by the tolerability and safety concerns. Lutikizumab is a novel anti-IL-1α/β dual variable domain immunoglobulin that can simultaneously bind and inhibit IL-1α and IL-1β to relieve the pain and dysfunction symptoms. We conducted this network meta-analysis to comprehensively compare the clinical efficacy and safety of lutikizumab with other drugs recommended by guidelines. We conducted a Bayesian network and conventional meta-analyses to compare the efficacy and safety of lutikizumab with other traditional drugs. All eligible randomized clinical trials, in PubMed, CNKI, EMBASE, and Web of Science databases, from January 2000 to January 2020, were included. The Cochrane risk of the bias assessment tool was used for quality assessment. Pain relief, function improvement, and risk of adverse effects (AEs) were compared in this study. 24 articles with 11858 patients were included. Duloxetine (DUL) had the largest effect for pain relief (4.76, 95% CI [2.35 to 7.17]), and selective cox-2 inhibitors (SCI) were the most efficacious treatment for ...Continue Reading

References

Dec 1, 1993·Annals of the Rheumatic Diseases·M N FarahatG S Panayi
Mar 17, 2001·Scandinavian Journal of Rheumatology·F McKennaG S Geis
Dec 23, 2003·Current Medical Research and Opinion·J ZacherUNKNOWN etoricoxib OA study group
Aug 18, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Arthur A M BookmanJ Zev Shainhouse
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
Oct 15, 2005·BMJ : British Medical Journal·Deborah M CaldwellJ P T Higgins
Feb 1, 2006·PharmacoEconomics·A E AdesGuobing Lu
Jul 13, 2006·Current Medical Research and Opinion·Theophilus J GanaUNKNOWN 023 Study Group
May 3, 2008·Endocrine Reviews·Joseph LorenzoYongwon Choi
Sep 5, 2008·PharmacoEconomics·Alex SuttonKeith Abrams
Nov 5, 2008·The Journal of Clinical Investigation·Fionula M Brennan, Iain B McInnes
Aug 28, 2010·The Journal of Pain : Official Journal of the American Pain Society·Catherine B JohannesRobert H Dworkin
Dec 2, 2010·Nature Reviews. Rheumatology·Mohit KapoorHassan Fahmi
Apr 9, 2011·Revista brasileira de anestesiologia·Caio Marcio Barros de OliveiraReynaldo Salomão
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Dec 18, 2013·Immunity·Cecilia GarlandaAlberto Mantovani
Jul 23, 2014·Current Medical Research and Opinion·Allan GibofskyClarence L Young
Jul 30, 2014·Cytokine·Rachel E MillerAnne-Marie Malfait
Mar 10, 2015·Lancet·S Glyn-JonesA J Carr
Dec 15, 2015·Nature Reviews. Rheumatology·Georg SchettBernhard Manger

❮ Previous
Next ❯

Citations

Jul 30, 2021·Journal of Leukocyte Biology·Yating YiJun Wang

❮ Previous
Next ❯

Software Mentioned

Aggregate Data Drug Information System ( ADDIS
MP
Stata
Cochrane

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.